DocDollars

Sun Pharmaceutical Industries Inc.

NJ · United States · Reporting entity ID 100000151589

Total reported 2019–2025
$87.4M
#109 of 2,960 reporting companies — 0.1% of all reported industry payments
$39.5M in general payments across 449,989 records, plus $47.9M in research funding across 16,239 records.

How it breaks down

General payments $39,470,765
Research funding $47,898,310

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Sun Pharmaceutical Industries Inc. reported $87.4M to US doctors and teaching hospitals from 2019 to 2025, ranking #109 of 2,960 reporting companies. 55% of that was research funding and 45% general payments such as consulting, speaking, food and travel. 449,989 general payment records and 16,239 research records were filed.

Common questions about Sun Pharmaceutical Industries Inc.

How much has Sun Pharmaceutical Industries Inc. paid US doctors?

Sun Pharmaceutical Industries Inc. reported $87,369,074 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $39,470,765 in general payments, $47,898,310 in research funding.

How does Sun Pharmaceutical Industries Inc. rank among drug and device companies?

It ranks #109 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Sun Pharmaceutical Industries Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.